Semaglutide and Risk of NAION-Additional Insights

Affiliations

¹ Department of Ophthalmology and the Neuro Ophthalmology Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
² Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

Joseph F Rizzo 3rd et al. JAMA Ophthalmol. 2025.

. 2025 Apr 1;143(4):315-316.

doi: 10.1001/jamaophthalmol.2025.0005.

¹ Department of Ophthalmology and the Neuro Ophthalmology Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
² Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

No abstract available

Comment in

Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy.
Cai CX, Hribar M, Baxter S, Goetz K, Swaminathan SS, Flowers A, Brown EN, Toy B, Xu B, Chen J, Chen A, Wang S, Lee C, Leng T, Ehrlich JR, Barkmeier A, Armbrust KR, Boland MV, Dorr D, Boyce D, Alshammari T, Swerdel J, Suchard MA, Schuemie M, Bu F, Sena AG, Hripcsak G, Nishimura A, Nagy P, Falconer T, DuVall SL, Matheny M, Viernes B, O'Brien W, Zhang L, Martin B, Westlund E, Mathioudakis N, Fan R, Wilcox A, Lai A, Stocking JC, Takkouche S, Lee LH, Xie Y, Humes I, McCoy DB, Adibuzzaman M, Areaux RG Jr, Rojas-Carabali W, Brash J, Lee DA, Weiskopf NG, Mawn L, Agrawal R, Morgan-Cooper H, Desai P, Ryan PB. Cai CX, et al. JAMA Ophthalmol. 2025 Apr 1;143(4):304-314. doi: 10.1001/jamaophthalmol.2024.6555. JAMA Ophthalmol. 2025. PMID: 39976940 Free PMC article.